Myeloma
Survival is lowered in patients with chromosome abnormalities
Published in Cancer Weekly, April 29th, 2003
"The nonrandom recurrent nature of chromosome abnormalities in myeloma suggests a role for them in disease pathogenesis. We performed a careful cytogenetic analysis of patients with abnormal karyotypes (n=254), to discern patterns of association, search for novel abnormalities and elucidate clinical implications. Patients with karyotypic abnormalities suggestive of myelodysplasia/acute leukemia were excluded," scientists in the United States report.
"In this study we compared survival by abnormality only between patients with abnormal karyotypes. Patients with abnormalities...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-04-29)
More Articles from Cancer Weekly
- Lung Cancer
Researcher shows aggregation of cancers in families of lung cancer patients - Metastasis
Major study suggests "squirting" as key to cancer's spread - Ovarian Cancer
Cyclooxygenase-1 promotes angiogenic growth factor production - Prostate Cancer
Study evaluates biology of prostate cancer progression in African American men - Stem Cell Transplantation
Low-intensity conditioning has limited benefit for renal, colon cancer patients - Transplant Medicine
Organ transplants may carry cancer risk - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
